Moderna’s work developing seasonal vaccines is ‘risky’ under current FDA, analyst says
The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development.
Last updated: 2026-02-12 04:10:43 ET
The biotech company said the FDA won’t review its flu vaccine, in the latest hit to mRNA development.
Gather AI, a startup developing physical AI for logistics, has raised $40 million in Series B funding led by Smith Point Capital Management. The inves...
Motiv Space Systems have reached a contractual agreement with PickNik Robotics to support software development for NASA’s Fly Foundational Robotics ...
Amazon (AMZN) stock developing AI content marketplace for publishers to license material to AI firms following Microsoft's similar platform launch las...
As the construction sector grapples with stubborn labor shortages, rising costs, and mounting pressure to deliver housing at scale, a new class of aut...
A brain-training game that takes about 2 hours a week can reduce your risk of developing dementia by 25%, study finds
Rising GDP continues to mean more carbon emissions and wider damage to the planet. Can the two be decoupled?During Cop30 negotiations in Brazil last y...
Until announcing the Saudi commitment, North America’s only producer of natural graphite had been developing plans to build battery material facili...
Police say they won't speculate on the intent of the accused, who appeared to have been developing an anti-drone weapons system to meet "military dema...
The Republican foreign-policy establishment is developing a robust middle way between primacy and restraint.